Research of Ovarian Carcinosarcoma has been linked to Ovarian Neoplasm, Neoplasms, Carcinosarcoma, Malignant Paraganglionic Neoplasm, Malignant Neoplasms. The study of Ovarian Carcinosarcoma has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Ovarian Carcinosarcoma include Pathogenesis, Cell Differentiation, Angiogenesis, Response To Paclitaxel, Localization. These pathways complement our catalog of research reagents for the study of Ovarian Carcinosarcoma including antibodies and ELISA kits against CARCINOEMBRYONIC ANTIGEN, KI67, BRCA1, BRCA2, CD34.
Ovarian Carcinosarcoma Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Ovarian Carcinosarcoma below!
For more information on how to use Laverne, please read the How to Guide.
We have 2513 products for the study of Ovarian Carcinosarcoma that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Ovarian Carcinosarcoma is also known as ovarian carcinosarcoma, ovarian malignant mesodermal (mullerian) mixed tumor, malignant mixed mullerian tumor of the ovary, ovarian malignant mixed mullerian tumor, ovarian mmmt.